Dubai: Are you someone who suffers from throbbing headaches, with a specific smell or light triggering nausea, vomiting and a debilitating pain in the head periodically? It is likely that you are a victim of migraine, which has been recognised as the second-highest cause of disability in the UAE with one in five individuals suffering from it. Conventionally, migraines were being treated with painkillers, anti-depressants, anti-epileptic drugs and tryptamine-based drugs, with little hope of reducing the intensity or frequency. Now you need not suffer any more. A new treatment called the Anti-CGRP (calcitonin gene-related peptide) targets the pain specifically caused by the CGRP neuropeptide by inhibiting it, thereby mitigating the pain and managing it to near minimum. The therapy not only reduces the periodicity and intensity of these headaches, but also helps you manage it so effectively that migraine patients suffer no loss of productivity at work or enjoyment hours during leisure.